We offer a range of specialized genetic tests including Non-Invasive Prenatal Testing (NIPT), Karyotyping, FISH for Aneuploidy, Chromosomal Microarray (CMA), and QF-PCR for Aneuploidy. These tests help in prenatal screening, diagnosing genetic conditions, and understanding causes of developmental delays or pregnancy loss.
Most of our genetic tests require a referral from your doctor or a qualified healthcare professional. They can discuss which test is appropriate for you and help arrange sample collection.
Yes, Suraksha Genomics strongly believes in the importance of genetic counseling. Our team, or your referring doctor, can help you understand the implications of genetic testing, interpret results, and discuss any further steps.
Suraksha Genomics is committed to:
CMA is an advanced genetic test that analyzes chromosomes at a very detailed level. It can detect tiny missing (microdeletions) or extra (microduplications) pieces of genetic material, known as copy number variations (CNVs), which are too small to be seen by traditional Karyotyping.
We utilize advanced Cytoscan Optima & 750K microarray platforms for high- resolution genetic analysis.
We can perform CMA on:
CMA is recommended as a first-tier test for individuals with:
CMA provides a much higher resolution genetic map than Karyotyping, significantly increasing the diagnostic yield by detecting smaller genetic imbalances that can cause various health and developmental conditions.
Quantitative Fluorescent Polymerase Chain Reaction (QF-PCR) is a rapid molecular genetic test used to quickly count the number of specific chromosomes. It's highly effective for detecting common aneuploidies.
Our QF-PCR test screens for aneuploidies involving:
QF-PCR can be performed on Amniotic Fluid (AF), Chorionic Villus Samples (CVS), or blood samples.
QF-PCR is often used when rapid detection of common aneuploidies is critical, such as in prenatal diagnosis following a high-risk screening result, or for newborns with suspected chromosomal disorders. It provides results much faster than Karyotyping.
Fluorescence In Situ Hybridization (FISH) is a rapid genetic test used to quickly detect common numerical chromosomal abnormalities. It uses fluorescent probes that bind to specific chromosomes.
FISH is often used when rapid results are needed for suspected common aneuploidies, especially in prenatal samples (Amniotic Fluid or CVS) or in newborns with features suggestive of these conditions.
Karyotyping is a genetic test that examines an individual's chromosomes – the structures that hold our DNA. It creates a "picture" of the chromosomes to count them and look for large changes in their size or structure, which can indicate genetic conditions.
We perform Karyotyping on:
Karyotyping may be recommended for individuals with suspected chromosomal syndromes (like Down syndrome), developmental delays, intellectual disabilities, infertility, recurrent pregnancy loss, or when prenatal screening suggests a chromosomal abnormality.
It can detect numerical abnormalities (e.g., an extra or missing chromosome) and large structural rearrangements (e.g., translocations, large deletions or duplications).
NIPT is a safe and highly accurate blood screening test for pregnant women. It analyzes small fragments of your baby's DNA (cell-free DNA) that circulate in your bloodstream to assess the likelihood of certain chromosomal conditions.
NIPT is recommended and can be offered to all pregnant women, regardless of age or risk level, as early as 10 weeks of pregnancy.
It involves a simple blood draw from the mother's arm. There is no risk to the baby.
A high-risk NIPT result indicates an increased chance of a chromosomal condition, but it is not a diagnosis. Your doctor or a genetic counselor will discuss the result with you and may recommend confirmatory diagnostic testing like amniocentesis or CVS, followed by tests like Karyotyping or Microarray.